First Time Loading...

Redhill Biopharma Ltd
NASDAQ:RDHL

Watchlist Manager
Redhill Biopharma Ltd Logo
Redhill Biopharma Ltd
NASDAQ:RDHL
Watchlist
Price: 0.451 USD 4.57% Market Closed
Updated: May 2, 2024

Redhill Biopharma Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Redhill Biopharma Ltd
Operating Income Peer Comparison

Comparables:
T
TEVA
TARO
I
INCR
MDWD
R
REKA

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Redhill Biopharma Ltd
NASDAQ:RDHL
Operating Income
$12.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Operating Income
$3.5B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
-1%
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Operating Income
$22m
CAGR 3-Years
-49%
CAGR 5-Years
-40%
CAGR 10-Years
-25%
I
InterCure Ltd
TASE:INCR
Operating Income
₪40m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Operating Income
-$15.5m
CAGR 3-Years
-21%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Operating Income
₪5.6m
CAGR 3-Years
-31%
CAGR 5-Years
-16%
CAGR 10-Years
-10%

See Also

What is Redhill Biopharma Ltd's Operating Income?
Operating Income
12.6m USD

Based on the financial report for Dec 31, 2023, Redhill Biopharma Ltd's Operating Income amounts to 12.6m USD.